125 related articles for article (PubMed ID: 16862076)
1. Immunohistochemical expression of heparan sulfate correlates with stromal cell proliferation in breast phyllodes tumors.
Koo CY; Bay BH; Lui PC; Tse GM; Tan PH; Yip GW
Mod Pathol; 2006 Oct; 19(10):1344-50. PubMed ID: 16862076
[TBL] [Abstract][Full Text] [Related]
2. Associations of epithelial c-kit expression in phyllodes tumours of the breast.
Tawasil J; Go EM; Tsang JY; Ni YB; Ko CW; Tse GM
J Clin Pathol; 2015 Oct; 68(10):808-11. PubMed ID: 26056158
[TBL] [Abstract][Full Text] [Related]
3. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.
Tan PH; Jayabaskar T; Yip G; Tan Y; Hilmy M; Selvarajan S; Bay BH
Mod Pathol; 2005 Dec; 18(12):1527-34. PubMed ID: 16258510
[TBL] [Abstract][Full Text] [Related]
4. An approach to malignant mammary phyllodes tumors detection.
Ilić I; Randelović P; Ilić R; Katić V; Milentijević M; Velicković L; Krstić M
Vojnosanit Pregl; 2009 Apr; 66(4):277-82. PubMed ID: 19441158
[TBL] [Abstract][Full Text] [Related]
5. p53 protein expression and gene mutation in phyllodes tumors of the breast.
Gatalica Z; Finkelstein S; Lucio E; Tawfik O; Palazzo J; Hightower B; Eyzaguirre E
Pathol Res Pract; 2001; 197(3):183-7. PubMed ID: 11314782
[TBL] [Abstract][Full Text] [Related]
6. CD117 expression in breast phyllodes tumors correlates with adverse pathologic parameters and reduced survival.
Tan WJ; Thike AA; Tan SY; Tse GM; Tan MH; Bay BH; Tan PH
Mod Pathol; 2015 Mar; 28(3):352-8. PubMed ID: 25216225
[TBL] [Abstract][Full Text] [Related]
7. Expression of Yes-associated protein (YAP) in breast phyllodes tumor.
Kim SK; Jung WH; Koo JS
Int J Clin Exp Pathol; 2014; 7(9):5997-6005. PubMed ID: 25337244
[TBL] [Abstract][Full Text] [Related]
8. Patterns of p53 expression in phyllodes tumors of the breast--an immunohistochemical study.
Kim CJ; Kim WH
J Korean Med Sci; 1993 Oct; 8(5):325-8. PubMed ID: 8305139
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53 protein and Ki-67 antigen in phyllodes tumor of the breast.
Chan YJ; Chen BF; Chang CL; Yang TL; Fan CC
J Chin Med Assoc; 2004 Jan; 67(1):3-8. PubMed ID: 15077883
[TBL] [Abstract][Full Text] [Related]
10. Proliferating activity in the epithelial and stromal component of fibroadenomas and phyllodes tumours of the breast.
Barwijuk-Machała M; Reszeć J; Baltaziak M; Musiatowicz B; Cylwik J
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():55-7. PubMed ID: 15638374
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of MIB1 expression in phyllodes tumor and fibroadenoma.
Umekita Y; Yoshida H
Pathol Int; 1999 Sep; 49(9):807-10. PubMed ID: 10504552
[TBL] [Abstract][Full Text] [Related]
12. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
Kleer CG; Giordano TJ; Braun T; Oberman HA
Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features.
Shpitz B; Bomstein Y; Sternberg A; Klein E; Tiomkin V; Kaufman A; Groisman G; Bernheim J
J Surg Oncol; 2002 Feb; 79(2):86-92. PubMed ID: 11815995
[TBL] [Abstract][Full Text] [Related]
14. Utility of Ki-67, CD10, CD34, p53, CD117, and mast cell content in the differential diagnosis of cellular fibroadenomas and in the classification of phyllodes tumors of the breast.
Vilela MH; de Almeida FM; de Paula GM; Ribeiro NB; Cirqueira MB; Silva AL; Moreira MA
Int J Surg Pathol; 2014 Sep; 22(6):485-91. PubMed ID: 24492332
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical profile of cystosarcoma phyllodes of the breast: a study of 23 cases.
Dacic S; Kounelis S; Kouri E; Jones MW
Breast J; 2002; 8(6):376-81. PubMed ID: 12390361
[TBL] [Abstract][Full Text] [Related]
16. 2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.
Tan PH
Ann Acad Med Singap; 2005 Dec; 34(11):671-7. PubMed ID: 16453039
[TBL] [Abstract][Full Text] [Related]
17. Multinucleated stromal giant cells in mammary phyllodes tumours.
Tse GM; Law BK; Chan KF; Mas TK
Pathology; 2001 May; 33(2):153-6. PubMed ID: 11358046
[TBL] [Abstract][Full Text] [Related]
18. Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast.
Kucuk U; Bayol U; Pala EE; Cumurcu S
Indian J Pathol Microbiol; 2013; 56(2):129-34. PubMed ID: 24056649
[TBL] [Abstract][Full Text] [Related]
19. CD10+ stromal cells in fibroadenomas and phyllodes tumors of the breast.
Zamecnik M; Kinkor Z; Chlumska A
Virchows Arch; 2006 Jun; 448(6):871-2. PubMed ID: 16550395
[No Abstract] [Full Text] [Related]
20. Expression of c-kit in fibroepithelial lesions of the breast is a mast cell phenomenon.
Djordjevic B; Hanna WM
Mod Pathol; 2008 Oct; 21(10):1238-45. PubMed ID: 18500266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
